| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/03/2008 | US20080160039 Pneumovirus NS proteins antagonize the interferon IFN response |
| 07/03/2008 | US20080160038 Non-anaphylactic Forms of Grass Pollen Ph1 p 6 Allergen and Their Use |
| 07/03/2008 | US20080160037 Novel beta-defensins |
| 07/03/2008 | US20080160036 Protein fusion for use as antagonist to V-set domain containing T cell activation inhibitor 1(B7 H4); treating rheumatoid atrhritis, cardiomyopathy, skin, liver and connective tissue disorders |
| 07/03/2008 | US20080160032 Using interleukin beta specific immunoglobulin as blocking agent and preventative of juvenile idiopathic arthritis |
| 07/03/2008 | US20080160026 Apo-2 ligand-anti-her-2 antibody synergism |
| 07/03/2008 | US20080160025 Glucocorticoid mixture for use in treatment and prevention of autoimmune, bone and skin disorders; tumor necrosis factor-immunoglobulin fusion for use in immnosuppressive therapy |
| 07/03/2008 | US20080160024 Inhibition of cancer metastasis |
| 07/03/2008 | US20080160022 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 07/03/2008 | US20080160018 Using mik- beta 1 monoclonal antibody as therapeutic tool in treatment and prevention of graft vs. host, autoimmune and diabetic disorders |
| 07/03/2008 | US20080160017 Cross-Linked Antibodies |
| 07/03/2008 | US20080160013 Using immunoglobulin fusion comprising intergrin binding protein and src homology domains as therapeutic tool in treatment and prevention of cell proliferative and atherosclerotic disorders |
| 07/03/2008 | US20080160010 Peptide That Elicits Neutralizing Antibodies Targeting the Hiv Co-Receptor |
| 07/03/2008 | US20080160008 Methods and compositions for reducing amyloid beta levels |
| 07/03/2008 | US20080160007 Diagnosis and treatment of cancer related to human dormancy |
| 07/03/2008 | US20080160006 Nutrient broth for maintenance of brain or spinal cord tissue |
| 07/03/2008 | US20080160005 Interleukin-6 suppressive agent |
| 07/03/2008 | US20080160003 Using mixture comprising glycosylphosphatidylinositol (GPI anchor ) and sperm adhesion molecule-1to improve success rate of artificiial insemination |
| 07/03/2008 | US20080160002 Tumor necrosis factor cleaving agent for use in diagnosis, prevention and treatment of inflammatory disorders |
| 07/03/2008 | US20080160001 Statin mixture for use in lowering blood fat, protecting and repairing liver, kidney, heart, blood vessels and/or muscle |
| 07/03/2008 | US20080159997 Transplants for myocardial scars |
| 07/03/2008 | US20080159993 Immunotherapeutic methods using epitopes of WT-1 and GATA-1 |
| 07/03/2008 | US20080159992 membrane polypeptide for use in designing therapeutic for use treatment and prevention of cell proliferative, inflammatory, skin, arthritic, cardiovascular and autoimmune disorders |
| 07/03/2008 | US20080159991 Using hormone treatments to prevent and/or treat glucose metabolism disorers |
| 07/03/2008 | US20080159989 Method of Promoting the Differentiation of Staminal Cells |
| 07/03/2008 | US20080159988 Materials and methods for treating or preventing oxalate-related disease |
| 07/03/2008 | US20080159986 Modulators of the functions of receptors of the tnf/ngf receptor family and other proteins |
| 07/03/2008 | US20080159985 Matrix material comprising electrodeposited biopolymers and/or pharmeceuticals for use in transfer and release of compounds into cells |
| 07/03/2008 | US20080159984 Compositions Capable of Facilitating Penetration Across a Biological Barrier |
| 07/03/2008 | US20080159983 Using antisense, ,immunmoglobulin and/or ribozymal agents to treat blood disorders |
| 07/03/2008 | US20080159982 ethyl 2-(biphenyl-4-yl)-6-(tert-butoxycarbonylamino)-2-methoxy-8-(2-nitrophenylsulfonyl)-5,16-dioxo-1,2,3,5,6,7,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[n]pyrrolo[2,1-c][1,4,8]triazacyclopentadecine-14a-carboxylate; viricide; synergistic with other active ingredients |
| 07/03/2008 | US20080159981 Methods of therapy for cancers characterized by overexpression of the HER2 receptor protein |
| 07/03/2008 | US20080159980 Glutathione s-transferase (GST); kits |
| 07/03/2008 | US20080159979 Treatment of wounds using il-17b |
| 07/03/2008 | US20080159978 Using bioactive compounds to induce or accelerate healing of damaged skin |
| 07/03/2008 | US20080159977 Modified, protease resistant, colony stimulating factor for use in treatment and prevention of autoimmune and cell proliferative diseases; directed protein evolution |
| 07/03/2008 | US20080159964 As polymer conjugates; reduced side effects; inhalation formulations and kits |
| 07/03/2008 | US20080159962 administering Angiotensin Converting enzyme 2 (ACE2) for treating infection with acute respiratory Syndrome (SARS) Coronavirus; including AT1-inhibitor, AT2-agonist, a bradykinin receptor inhibitor, a renin inhibitor and/or an ACE inhibitor |
| 07/03/2008 | US20080159959 antiinflammatory agents has water-soluble N-(2-hydroxypropyl) methacrylamide copolymer linked to a glucocorticoid; drug conjugated with a polymer for targeting to bone or cartilage tissue; treatment of rheumatoid arthritis using MR imaging techniques |
| 07/03/2008 | US20080159956 diagnosing and analyzing a mammal who has a risk of developing the disease, using antibody, or fragments thereof, which has a binding site specific for integrin |
| 07/03/2008 | CA2709428A1 Adp-ribosyl transferase fusion variant proteins |
| 07/03/2008 | CA2673714A1 Fermented milk for skin improvement and/or treatment and process for producing the same |
| 07/03/2008 | CA2673678A1 Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections |
| 07/03/2008 | CA2673657A1 Use of long-acting glp-1 receptor agonists to improve insulin sensitivity and lipid profiles |
| 07/03/2008 | CA2673600A1 Surgical applications for bmp binding protein |
| 07/03/2008 | CA2673560A1 New fusion molecule based on novel taa variant |
| 07/03/2008 | CA2673539A1 Fluidized spray drying |
| 07/03/2008 | CA2673525A1 Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them |
| 07/03/2008 | CA2673522A1 Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer |
| 07/03/2008 | CA2673459A1 Modified coagulation factors with prolonged in vivo half-life |
| 07/03/2008 | CA2673446A1 Synergistic therapeutic use of prothrombin complex concentrates with fviii concentrates |
| 07/03/2008 | CA2673398A1 Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis |
| 07/03/2008 | CA2673382A1 Consensus biomineralization peptide |
| 07/03/2008 | CA2673248A1 Novel peptides |
| 07/03/2008 | CA2673176A1 Use of polypeptides as coccidiostat and /or histomonastat |
| 07/03/2008 | CA2672750A1 Trkb agonists for treating autoimmune disorders |
| 07/03/2008 | CA2671358A1 Novel anti-microbial peptidomimetic compounds and methods to calculate anti-microbial activity |
| 07/03/2008 | CA2670643A1 Lipase variants for pharmaceutical use |
| 07/02/2008 | EP1939297A1 Alzheimer's disease secretase |
| 07/02/2008 | EP1939295A1 Vaccine compostions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 07/02/2008 | EP1939291A2 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 07/02/2008 | EP1939290A2 Gene expression control |
| 07/02/2008 | EP1939286A1 Novel peptides |
| 07/02/2008 | EP1939218A1 Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof |
| 07/02/2008 | EP1939216A1 Immunomodulating composition |
| 07/02/2008 | EP1939213A1 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease |
| 07/02/2008 | EP1938834A1 Treatment of type 1 diabetes before and after expression of predisposition markers |
| 07/02/2008 | EP1938832A1 Angiotensin-converting enzyme inhibitory peptides |
| 07/02/2008 | EP1938831A1 Novel exendin agonist compounds |
| 07/02/2008 | EP1938830A1 Novel exendin agonist compounds |
| 07/02/2008 | EP1938799A1 Methods and compositions for treating and preventing posterior segment ophthalmic disorders |
| 07/02/2008 | EP1937843A1 POLYMORPHISMS IN PONl ARE ASSOCIATED WITH ELEVATED ALANINE AMINOTRANSFERASE LEVELS AFTER XIMELAGATRAN OR TACRINE ADMINISTRATION |
| 07/02/2008 | EP1937820A2 System for delivering neuronal calcium sensor-1 (ncs-1) |
| 07/02/2008 | EP1937815A1 Methods and compositions for modulating tumor cell activity |
| 07/02/2008 | EP1937799A1 Compositions and methods for culturing embryos and oocytes |
| 07/02/2008 | EP1937725A1 Tissue inhibitor of metalloproteinases (timp) linked to glycosylphosphatidylinositol (gpi) -anchors for treatment of cancer and skin lesions |
| 07/02/2008 | EP1937723A1 Modified chaperonin 10 |
| 07/02/2008 | EP1937716A2 Analogs of gastric inhibitory polypeptide as a treatment for age related decreased pancreatic beta cell function |
| 07/02/2008 | EP1937711A1 Epitopes, combined epitopes, use of epitopes or their combination, composition, uses of the composition, anti- hiv-i prophylactic vaccines, therapeutic vaccines, method for the identification of epitopes and methods for treatment and prevention |
| 07/02/2008 | EP1937710A1 Kinin b1 receptor peptide agonists and uses thereof |
| 07/02/2008 | EP1937701A2 Cross-linked polysaccharide and protein matrices and methods for their preparation |
| 07/02/2008 | EP1937298A1 Use of lactoferrin fragments and hydrolysates |
| 07/02/2008 | EP1937297A2 Use of a glp-1 molecule for treatment of biliary dyskinesia and/or biliary pain/discomfort |
| 07/02/2008 | EP1937296A2 Compounds for improving nutritional status, cognition and survival |
| 07/02/2008 | EP1937295A2 Treatment of retinopathies using gfr 3 agonists |
| 07/02/2008 | EP1937294A1 Glycolated and glycosylated poultry derived therapeutic proteins |
| 07/02/2008 | EP1937293A2 Method of repairing meniscal tears |
| 07/02/2008 | EP1937292A1 Lopap-based pharmaceutical compositions and uses thereof |
| 07/02/2008 | EP1937291A2 Use of ephrinb2 directed agents for the treatment of prevention of viral infections |
| 07/02/2008 | EP1937290A1 Prevention and treatment of drug-associated ocular side effects with a cyclosporin |
| 07/02/2008 | EP1937277A1 Method of acting upon organism by targeted delivery of biologicaly active substances into m itochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose |
| 07/02/2008 | EP1937256A2 Antiviral therapy with carbohydrate binding agents |
| 07/02/2008 | EP1937236A2 Modulation of neurogenesis by hdac inhibition |
| 07/02/2008 | EP1937213A1 Systems and methods for manufacturing liposomes |
| 07/02/2008 | EP1937084A2 Use of fructanases in feed of hoofed animals to treat and prevent laminitis |
| 07/02/2008 | EP1817052A4 Compositions and methods for the treatment of autism |
| 07/02/2008 | EP1756142B1 Pseudopeptides growth hormone secretagogues |
| 07/02/2008 | EP1667521A4 Methods for treatment of insulin-like growth factor-1 (igf-1) deficiency |
| 07/02/2008 | EP1631375A4 Injectable hydrogel microspheres from aqueous two-phase system |
| 07/02/2008 | EP1459762B1 Use of emp9 for the prevention of proliferative organ diseases |